Cerebral creatine deficiency syndromes: New in vivo AAV approaches to treat SLC6A8 deficiency by Edward Taberner | Oct 3, 2022
Autologous human induced pluripotent stem cells-derived neurons, astrocytes and oligodendrocytes as T cells targets in multiple sclerosis by Edward Taberner | Sep 29, 2022